Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein

被引:130
作者
Ayesh, S [1 ]
Shao, YM [1 ]
Stein, WD [1 ]
机构
[1] HEBREW UNIV JERUSALEM,SIBERMAN INST LIFE SCI,IL-91904 JERUSALEM,ISRAEL
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1996年 / 1316卷 / 01期
关键词
P-glycoprotein; modulator interaction; cooperativity; interaction; competitive; non-competitive; multidrug resistance;
D O I
10.1016/0925-4439(96)00008-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We measured the effects of individual modulators and of pairs of modulators of the multidrug resistance pump, P-glycoprotein, on the accumulation of labelled daunomycin into multidrug-resistant P388 leukemia cells at 37 degrees C and developed a kinetic analysis which enables such data to be modelled in terms of co-operative, competitive or non-competitive interaction between pairs of modulators. The modulators verapamil, cyclosporin and trifluoperazine interacted with P-glycoprotein as single molecules, while vinblastine, mefloquine, dipyridamole, tamoxifen and quinidine displayed Hill numbers close to 2, suggesting that pairs of modulator molecules need to act together in order to bring about effective reversal of P-glycoprotein. When the modulators were presented to P-glycoprotein in pairs, we found examples of both competitive and non-competitive behaviour. We interpret these results on a model in which two modulatory sites exit on the MDR pump. To one of these, mefloquine, vinblastine and tamoxifen bind preferentially; to the other, verapamil, dipyridamole, trifluoperazine and quinidine bind (but mefloquine and tamoxifen only weakly if at all). Cyclosporin A can interact with both sites.
引用
收藏
页码:8 / 18
页数:11
相关论文
共 41 条
[21]   SYNERGISTIC INTERACTION OF CYCLOSPORINE-A AND VERAPAMIL ON VINCRISTINE AND DAUNORUBICIN RESISTANCE IN MULTIDRUG-RESISTANT HUMAN LEUKEMIA-CELLS INVITRO [J].
OSANN, K ;
SWEET, P ;
SLATER, LM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (02) :152-154
[22]   NONCOMPETITIVE INHIBITION OF P-GLYCOPROTEIN-ASSOCIATED EFFLUX OF THP-ADRIAMYCIN BY VERAPAMIL IN LIVING K562 LEUKEMIA-CELLS [J].
PEREIRA, E ;
BORREL, MN ;
FIALLO, M ;
GARNIERSUILLEROT, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1225 (02) :209-216
[23]  
RAMU A, 1984, CANCER RES, V44, P4392
[24]   REVERSAL OF MULTIDRUG RESISTANCE BY PHENOTHIAZINES AND STRUCTURALLY RELATED-COMPOUNDS [J].
RAMU, A ;
RAMU, N .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (03) :165-173
[25]  
RAO US, 1994, MOL PHARMACOL, V45, P773
[26]  
Reynolds JEF, 1993, MARTINDALE EXTRA PHA
[27]  
SAMUELS BL, 1991, CANCER RES, V51, P1749
[28]  
SARKADI B, 1992, J BIOL CHEM, V267, P4854
[29]  
Segel I.H., 1975, Enzyme kinetics
[30]  
SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745